To include your compound in the COVID-19 Resource Center, submit it here.

NaPro BioTherapuetics Inc., University of Delaware, Thomas Jefferson University deal

NPRO received exclusive worldwide rights from the

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE